JTC-801 Catalog No.:M10699-2 Smiles: [2H]C1C(C2=CC=CC=C2C2=NNN=N2)=C([2H])C([2H])=C(CN2C(CO)=C(Cl)N=C2CCCC)C=1[2H]

Smiles: [2H]C1C(C2=CC=CC=C2C2=NNN=N2)=C([2H])C([2H])=C(CN2C(CO)=C(Cl)N=C2CCCC)C=1[2H]

3-dihydroxy-12-methoxy-6-(4-methoxyphenyl)-5-phenyl-7-oxatricyclo[6

17-11-9-8-10-12-17)15-28-21(24)16-13-18(25-4)20(27-6)19(14-16)26-5

3S)-3-hydroxy-3-(hydroxycarbamoyl)-2-(2-methylpropyl)propanamido]-2-phenylacetate

01) and the total time spent in EEG seizure activity by 30 to 50% (p<0

JTC-801 Catalog No.:M10699-2 Smiles: [2H]C1C(C2=CC=CC=C2C2=NNN=N2)=C([2H])C([2H])=C(CN2C(CO)=C(Cl)N=C2CCCC)C=1[2H]JTC 801 is an opioid analgesic drug used in scientific research. JTC 801 is a selective antagonist for the nociceptin receptor, also known as the ORL 1 receptor. The noiciceptin receptor has complex effects which are involved in many processes involved in pain and inflammation responses, and activation of this receptor can either increase or reduce pain depending on dose. Drugs acting at the noiciceptin receptor may influence the effects of